biOasis Technologies Ord Shs BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

GREY:BIOAF - Post by User

biOasis Technologies Ord Shs > Chiesi

<< Previous

Bullboard Posts

Next >>

Comment by beenthereon Jan 09, 2023 5:47pm

135 Views

Post# 35212196

RE:RE:Chiesi

JD, that's an understatement!!

THREE PENNIES vs $ 14.50!!

PLEASE go away !

THAT'S THE LEAST YOU COULD DO FOR US!

FOR ME YOU REPRESENT $ 200 000 PLUS of my hard earned money GONE!

PLease do the right thing here and disappear! Move on and do your thing elsewhere!

I know most here hate me but it's time to agree with me!

Please agree with this post and maybe he will get the hint!